Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Howard Liu, D.S.

Concepts (51)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Radiosurgery5202313291.170 Why?
Oropharyngeal Neoplasms320214771.090 Why?
Lymphatic Metastasis2202129240.820 Why?
Alphapapillomavirus220212210.770 Why?
Papillomavirus Infections3202115870.700 Why?
Mouth Neoplasms220226010.660 Why?
Radiation Oncology120235550.610 Why?
Papillomaviridae3202111190.580 Why?
Carcinoma, Hepatocellular3202122140.490 Why?
Liver Neoplasms3202142530.390 Why?
Lymph Nodes1202134740.340 Why?
Head and Neck Neoplasms4202227340.280 Why?
Carcinoma, Squamous Cell4202240340.250 Why?
Neck Dissection220201970.190 Why?
Australia1202111700.150 Why?
Retrospective Studies62021774490.110 Why?
Aged, 80 and over42022577760.100 Why?
Imaging, Three-Dimensional1202340420.090 Why?
Skin Neoplasms2202156860.090 Why?
Fluorodeoxyglucose F181201820160.090 Why?
Radiopharmaceuticals1201826450.080 Why?
Disease-Free Survival1201868950.080 Why?
Carcinoma, Renal Cell1202131430.070 Why?
Aged520221632800.070 Why?
Young Adult32022564300.060 Why?
Kidney Neoplasms1202142620.060 Why?
Radiotherapy, Adjuvant2202217700.060 Why?
Humans1320237443430.060 Why?
Neoplasm Recurrence, Local2202192390.060 Why?
Middle Aged520222133830.060 Why?
Smoking1202189870.060 Why?
Sensitivity and Specificity12018147220.060 Why?
Adult420222140550.060 Why?
Radiotherapy Dosage2202028790.050 Why?
Melanoma1202155100.050 Why?
Neoplasm Staging32021110310.050 Why?
Male620223501180.040 Why?
Female620223801940.040 Why?
Follow-Up Studies12018390500.040 Why?
Lung Neoplasms12021131020.040 Why?
Carboplatin120188010.030 Why?
Clinical Trials, Phase III as Topic120188410.030 Why?
Radiation Injuries1202011800.030 Why?
Postoperative Care1201814860.020 Why?
Combined Modality Therapy1202086420.020 Why?
Patient Selection1202042150.020 Why?
Prospective Studies22021532880.020 Why?
Survival Rate12018127880.010 Why?
Practice Guidelines as Topic1202072790.010 Why?
Randomized Controlled Trials as Topic1201899590.010 Why?
Treatment Outcome12021631140.010 Why?
Liu's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (51)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.